• Nenhum resultado encontrado

Evaluation of the Genotypic Pattern of HIV-1 Resistance in AIDS Patients Failing Antiretroviral Therapy

N/A
N/A
Protected

Academic year: 2019

Share "Evaluation of the Genotypic Pattern of HIV-1 Resistance in AIDS Patients Failing Antiretroviral Therapy"

Copied!
9
0
0

Texto

Loading

Imagem

Table 2. Frequency of mutations according to previous use of nucleoside reverse transcriptase inhibitors (NRTI)EvolutionCD4 (cells/mm3) ± SDVL (log 10) ± SD
Table 3. Frequency of mutations according to previous use of  NNRTI
Table 4.  Frequency of mutations according to previous use of PI No. patients Mutations       PI         51            44          19           33 IDV (%) NFV (%) SQV (%) RTV (%) 10F  5  ( 9.8)  5 (11.4)  1  (5.3)  3 (9.1) 10I 28 (54.9) 13 (29.5) 11 (57.9)
Figure 1. Mean frequency of mutations according to the number of NRTI previously used (p=0.027)
+2

Referências

Documentos relacionados

Evaluation of Viral Resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1- Infected Patients Before and After 6 Months of Single or Double Antiretroviral Therapy..

current reverse transcriptase and protease mutations multidrug resistance of HIV-1 isolates from heavily treated patients.. Larder BA, Darby G,

While PAHO recognizes the value of antiretroviral therapy (ARV) in the management of HIV infection and in the prevention of perinatal transmission of HIV, Member States need to view

Neste trabalho o objetivo central foi a ampliação e adequação do procedimento e programa computacional baseado no programa comercial MSC.PATRAN, para a geração automática de modelos

Ousasse apontar algumas hipóteses para a solução desse problema público a partir do exposto dos autores usados como base para fundamentação teórica, da análise dos dados

24. O Estado exportador de capitais pode regulamentar a liquidação dos investimentos de seus nacionais em território estrangeiro, mas a competência para a sua efetivação

In this work our purpose was to describe the genetic variability; prevalence of drug-resistance mutations; and genotypic resistance profiles in HIV-1 infected individu- als

diversity in the oral cavity of HIV-infected patients and to determine the level of resistance of the clinical isolates to antifungal agents.. MATERIALS